Nexpowder (endoscopic hemostasis system)

2022: System Release

In late September 2022, Medtronic announced the release of the Nexpowder endoscopic hemostasis system, which is designed to treat the most frequent gastrointestinal bleeding.

The apparatus uses non-contact, non-thermal and non-traumatic hemostatic powder. The powder is sprayed through a catheter having patented powder coating technology to minimize clogging. The design provides improved overview and control in the treatment of nonvaricosis bleeding in the upper gastrointestinal tract (GI). Upper GI bleeding accounts for 75% of all cases of acute GI bleeding, according to a press release.

Nexpowder (endoscopic hemostasis system)

Nexpowder powder is sprayed onto the target site endoscopically through a catheter that connects to the spray handle. Once sprayed, it forms a mucoadhesive and durable gel upon contact, with or without blood. The gel is then broken down within one to three days.

{{quote 'We are very pleased to offer the innovative Nexpowder system to gastroenterologists. We considered the potential impact on both physicians and patients, meeting the clear need to reduce upper GI bleeding mortality. The condition from which every 1 thousand people die, as well as in reducing repeated bleeding, which occurs in 20% of all cases of bleeding from the upper gastrointestinal tract. Medtronic GI is committed to creating transformative technologies that improve treatment outcomes and change standards of care, "said Gio Di Napoli, President of the GI Division of Medtronic. }} According to the developers, the spray sticks to the fabric with a vengeance of adhesion compared to other commercially available products. This provides a lasting hemostatic effect. In general, Nexpowder provides a solution to nonvaricosis bleeding from the upper GI with minimal dispersion or blockage, which allows for direct endoscopic visibility without deterioration. The system also does not require CO2 or air compressors. Its patented hydrophilic polymer provides controlled delivery to minimize blockage and maintain endoscopic visibility.^[1]

Notes